Combine and Conquer: A Treatment Strategy to Combat Drug-Use Associated Infections
Sandra Springer, MD, and Laura Marks, MD, PhD, highlight the need for a combined treatment approach for patients with drug-use associated infections.
Sandra Springer, MD, and Laura Marks, MD, PhD, highlight the need for a combined treatment approach for patients with drug-use associated infections.
Investigators conducted a study to determine the effect of syringes with fixed needles vs those with detachable needles on the risk for hepatitis C virus transmission among people who use injectable drugs.
The draft recommendation statement expands screening to asymptomatic individuals aged 18 to 79 years.
Sofosbuvir, velpatasvir and voxilaprevir are used for patients who have failed with direct-acting antivirals.
Rural counties seem to be the hardest hit and rates mirror opioid epidemic.
There were increased rates of subsequent Parkinson’s for those with hepatitis B, C, but not autoimmune hepatitis.